Category: Astrazeneca
EMA: Anaphylaxis and hypersensitivity reactions should be included in the list of possible side effects of the Astrazeneca vaccine
European Medicines Agency (EMA), the corona vaccine from the manufacturer Astra-Zeneca can cause severe allergic reactions. More...
Italy: Ten suspected of manslaughter after soldier dies following Astrazenica coronavirus vaccination with batch ABV2856
Stefano Paternò, a 43-year-old soldier serving in Sircusa, Italy, died yesterday morning of a cardiac arrest in his home . More...
AstraZeneca halves coronavirus vaccine delivery to the EU – export restrictions to blame
The European Commission received the message from AstraZeneca on Thursday afternoon (11 March 2021). More...
Astrazenica coronavirus vaccine: “We did not expect 40 percent side effects”
Shortly after the vaccination with the Astra-Zeneca active ingredient, 37 out of 88 employees in a Braunschweig, Germany clinic were temporarily unable to work. More...
25% of health workers in Sörmland, Sweden, report side effects to Astrazeneca coronavirus vaccine
In Sörmland, Sweden, a total of 400 hospital employees received a dose of AstraZeneca’s vaccine on Thursday. More...
About 20% of health workers in one Danish hospital vaccinated with the Astrazeneca vaccine experience mild side effects
The North Jutland Region of Denmark is to vaccinate one third of a hospital ward staff at a time instead of a half. More...
Oxford/AstraZeneca vaccine to be tested on children aged 6yrs to 17yrs
Trial will use 300 volunteers to assess whether jab produces strong immune response in children aged six to 17
Researchers will use 300 volunteers to assess whether the jab – known as the the ChAdOx1 nCoV-19 vaccine – produces a strong immune response in children aged between six and 17. More...
WHO recommends Oxford-AstraZeneca Covid-19 vaccine for all adults including over 65s
Scientists advising the World Health Organisation (WHO) have recommended the use of the Oxford-AstraZeneca Covid-19 vaccine in all adults – including those aged over 65 – after a number of countries opted not to adminster the jab to that group. More...
Oxford University: “vaccine effective against major B.1.1.7 ‘Kent’ coronavirus strain circulating in the UK”
“Data from our trials of the ChAdOx1 vaccine in the United Kingdom indicate that the vaccine not only protects against the original pandemic virus, but also protects against the novel variant, B.1.1.7”
The Oxford University researchers who developed the ChAdOx1-nCoV 19 vaccine have found that it remains effective against one of the new variants of the disease. More...
